Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Fontem Ventures BV | 11 |
| 2 | Societe des Produits Nestle SA | 7 |
| 3 | Nestle SA | 5 |
| 4 | E Nicotine Technology Inc | 2 |
| 5 | Massachusetts Institute of Technology | 2 |
| 6 | Nestec SA | 2 |
| 7 | Bpifrance Financement SA | 1 |
| 8 | Cedars-Sinai Medical Center | 1 |
| 9 | Fresenius SE and Co KGaA | 1 |
| 10 | University of California, San Diego | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 36 |
| 2 | A61P | Therapeutic activity (drug indications) | 32 |
| 3 | C07H | Sugars and derivatives | 20 |
| 4 | C07D | Heterocyclic compounds | 18 |
| 5 | A24F | 16 |
| 6 | A61M | Devices for introducing media into the body | 16 |
| 7 | Y02A | Climate change adaptation | 16 |
| 8 | C07C | Acyclic and carbocyclic compounds | 11 |
| 9 | A24B | 10 | |
| 10 | A01N | Preservation of bodies; biocides; pest repellents | 9 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Advanced Glycation End Products research | 1 |
| 2 | Leprosy Research and Treatment | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | L. Mester | Institut de Chimie des Substances Naturelles | 8 |
| 2 | Mester de Parajd L | 7 | |
| 3 | Mester de Parajd M | 6 | |
| 4 | N. H. Antia | Foundation for Medical Research | 4 |
| 5 | E. J. AMBROSE | Foundation for Medical Research | 3 |
| 6 | G Baquillon | 3 | |
| 7 | László Szabados | Institut de Chimie des Substances Naturelles | 3 |
| 8 | M. Mester | Institut de Chimie des Substances Naturelles | 3 |
| 9 | P. R. Mahadevan | Foundation for Medical Research | 3 |
| 10 | S Balakrishnan | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Inhibition of the incorporation of [3H]DOPA in Mycobacterium leprae by desoxyfructo-serotonin | 1980 | 8 | Leprosy Research and Treatment |
| Maillard type carbonyl-amine reactions in vivo and their physiological effects. | 1981 | 5 | Advanced Glycation End Products research |
| EFFECT OF DEOXYFRUCTOSEROTONIN (DFS) ON LEPROMATOUS LEPROSY | 1988 | 5 | Leprosy Research and Treatment |
| Deoxyfructo-serotonin: a new drug with anti-leprosy activity. | 1983 | 4 | Cancer Treatment and Pharmacology |
| The action of deoxyfructose serotonin on intracellular bacilli and on host response in leprosy | 1985 | 4 | Diet, Metabolism, and Disease |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Deoxyfructo-serotonin?
Which organizations hold the most patents related to Deoxyfructo-serotonin?
What research topics are associated with Deoxyfructo-serotonin in the scientific literature?
Which author has published the most papers on Deoxyfructo-serotonin?
What is the most common patent classification associated with Deoxyfructo-serotonin?